Literature DB >> 27255295

Association between SLC2A9 (GLUT9) gene polymorphisms and gout susceptibility: an updated meta-analysis.

Xu Zhang1, Xiao Yang1, Mengmeng Wang1, Xiaona Li1, Qing Xia1, Shengqian Xu2,3, Jianhua Xu2,3, Guoqi Cai1, Li Wang1, Lihong Xin1, Yanfeng Zou1, Faming Pan4,5.   

Abstract

The relationship between the SLC2A9 (solute carrier family 2, member 9) gene polymorphisms and gout was still inconsistent among the individual genetic association studies. Therefore, this present research was aimed to systematically evaluate the association between SLC2A9 gene polymorphisms and gout susceptibility. Relevant studies were enrolled by searching databases systematically. The pooled odds ratios (ORs) with 95 % confidence intervals (CIs) were used to assess the associations. The heterogeneity between each of the studies was calculated by using the Q statistic methods, and Begg's funnel plot and Egger's tests were performed to evaluate publication bias. A total of 13 studies investigated four single nucleotide polymorphisms (SNPs) in SLC2A9 were included. In this study, we found that the allele C of rs3733591 was higher in patients than in controls in both all-pooled population [C vs. T: OR (95 % CI) = 1.432 (1.213-1.691)] and Asians-pooled population [C vs. T: OR (95 % CI) = 1.583 (1.365-1.835)]. The allele frequency C of s6449213 was lower in the gout patients than in controls in both all-pooled population and Caucasians-pooled population. Additionally, the allele frequency T of rs16890979 and the allele frequency C of rs1014290 were lower in gout patients than in controls. This study demonstrated that the genetic susceptibility for gout is associated with the SLC2A9 gene polymorphisms. Four of them except for the rs3733591 are protective SNPs in Caucasians, and rs16890979 and rs1014290 are protective SNPs in both Caucasians and Asians, while rs3733591 may be susceptibility SNP in Asians.

Entities:  

Keywords:  Gout; Meta-analysis; Polymorphisms; SLC2A9

Mesh:

Substances:

Year:  2016        PMID: 27255295     DOI: 10.1007/s00296-016-3503-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  47 in total

1.  National prevalence of gout derived from administrative health data in Aotearoa New Zealand.

Authors:  Doone Winnard; Craig Wright; William J Taylor; Gary Jackson; Leanne Te Karu; Peter J Gow; Bruce Arroll; Simon Thornley; Barry Gribben; Nicola Dalbeth
Journal:  Rheumatology (Oxford)       Date:  2012-01-16       Impact factor: 7.580

2.  Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort.

Authors:  Vidula Bhole; Mary de Vera; M Mushfiqur Rahman; Eswar Krishnan; Hyon Choi
Journal:  Arthritis Rheum       Date:  2010-04

3.  Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study of 145 patients.

Authors:  Ozren Polasek; Grgo Gunjaca; Ivana Kolcić; Lina Zgaga; Snjezana Dzijan; Robert Smolić; Martina Smolić; Jasminka Milas-Ahić; Vatroslav Serić; Josip Galić; Sandra Tucak-Zorić; Antun Tucak; Igor Rudan; Gordan Lauc
Journal:  Croat Med J       Date:  2010-02       Impact factor: 1.351

Review 4.  Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.

Authors:  Bruce N Cronstein; Prashanth Sunkureddi
Journal:  J Clin Rheumatol       Date:  2013-01       Impact factor: 3.517

5.  Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking.

Authors:  Robert Augustin; Mary O Carayannopoulos; Lia O Dowd; John E Phay; Jeffrey F Moley; Kelle H Moley
Journal:  J Biol Chem       Date:  2004-01-22       Impact factor: 5.157

Review 6.  Unusual clinical presentations of gout.

Authors:  Tony C Ning; Robert T Keenan
Journal:  Curr Opin Rheumatol       Date:  2010-03       Impact factor: 5.006

7.  The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity.

Authors:  Jade E Hollis-Moffatt; Peter J Gow; Andrew A Harrison; John Highton; Peter B B Jones; Lisa K Stamp; Nicola Dalbeth; Tony R Merriman
Journal:  Arthritis Res Ther       Date:  2011-06-09       Impact factor: 5.156

8.  Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI.

Authors:  Anita Brandstätter; Stefan Kiechl; Barbara Kollerits; Steven C Hunt; Iris M Heid; Stefan Coassin; Johann Willeit; Ted D Adams; Thomas Illig; Paul N Hopkins; Florian Kronenberg
Journal:  Diabetes Care       Date:  2008-05-16       Impact factor: 19.112

9.  Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005.

Authors:  L Annemans; E Spaepen; M Gaskin; M Bonnemaire; V Malier; T Gilbert; G Nuki
Journal:  Ann Rheum Dis       Date:  2007-11-02       Impact factor: 19.103

Review 10.  Correlation of GLUT9 Polymorphisms With Gout Risk.

Authors:  Qingxi Meng; Ji Yue; Mingfu Shang; Qunqun Shan; Jian Qi; Zhaohu Mao; Jian Li; Fan Zhang; Baolong Wang; Tingbao Zhao; Weiguo Wang
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

View more
  4 in total

1.  Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up.

Authors:  Mehmet Kanbay; Constance Xhaard; Edith Le Floch; Claire Dandine-Roulland; Nicolas Girerd; João Pedro Ferreira; Jean-Marc Boivin; Sandra Wagner; Delphine Bacq-Daian; Jean-François Deleuze; Faiez Zannad; Patrick Rossignol
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

Review 2.  The Role of the Intestine in the Development of Hyperuricemia.

Authors:  Hui Yin; Na Liu; Jie Chen
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

Review 3.  Urate Transporters in the Kidney: What Clinicians Need to Know.

Authors:  Sungjin Chung; Gheun-Ho Kim
Journal:  Electrolyte Blood Press       Date:  2021-06-30

4.  The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.

Authors:  Thitiya Lukkunaprasit; Sasivimol Rattanasiri; Saowalak Turongkaravee; Naravut Suvannang; Atiporn Ingsathit; John Attia; Ammarin Thakkinstian
Journal:  BMC Med Genet       Date:  2020-10-21       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.